Clinical Trial: A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07911553) titled 'A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5' on Oct. 26.

Brief Summary: This is a study to evaluate the efficacy of surovatamig combined with rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) in participants aged 18 to < 80 years of age with previously untreated large B-cell lymphoma (LBCL) with International Prognostic Index (IPI) score 2 to 5.

Study Start Date: Dec. 22

Study Type: INTERVENTIONAL

Condition: Large B-cell Lymphoma

Intervention: DRUG: Surovatamig

Fully human bispecifi...